- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +10 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Renal Medullary Carcinoma
Explore clinical trials studying Renal Medullary Carcinoma. Study availability and eligibility vary by location and protocol.
8 public trials
3 recruiting studies
Renal Medullary Carcinoma trial results
NCT06444880
- Conditions
- Epithelioid Sarcoma, Neoplasms, Neoplasms by Histologic Type, +4 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT06302569
- Conditions
- Adenocarcinoma, Bellini Carcinoma, Carcinoma, +16 more
- Locations
-
- Fondazione Irccs Istituto Dei Tumori Di Milano Milan, Italy
NCT02875548
- Conditions
- Adenoma, Advanced Solid Tumors, Diffuse Large B-Cell Lymphoma (DLBCL), +24 more
- Locations
-
- University of Arizona Cancer Center Tucson, Arizona, United States
- California Cancer Associates For Research And Excellence, cCARE Santa Fe, California, United States
- Hematology Oncology Associates of the Treasure Coast - Port St. Lucie Port Saint Lucie, Florida, United States
- Moffitt Tampa, Florida, United States
NCT02601950
- Conditions
- Any Solid Tumor With an EZH2 GOF Mutation, Atypical Teratoid Rhabdoid Tumors (ATRT), Epithelioid Sarcoma, +14 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
- University of Colorado Denver Aurora, Colorado, United States
- Mayo Clinic - Jacksonville Jacksonville, Florida, United States
- Northwestern Memorial Hospital Chicago, Illinois, United States
NCT04537715
- Conditions
- Adenoma, Advanced Malignancies, All Malignancies, +32 more
- Locations
-
- California Cancer Associates for Research and Excellence, Inc. (cCARE) Encinitas, California, United States
- The Angeles Clinic and Research Institute Los Angeles, California, United States
- Northwestern University-Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
- South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
NCT00027820
- Conditions
- Adenocarcinoma, Adult Acute Myeloid Leukemia in Remission, Anemia, +72 more
- Locations
-
- University of Arizona Health Sciences Center Tucson, Arizona, United States
- Stanford University Hospitals and Clinics Stanford, California, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States
Active, Not Recruiting
Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla
NCT05347212
- Conditions
- Carcinoma, Carcinomas, Neoplasms, +3 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States